News | February 27, 2026
Star Health & Allied Insurance rolls out 32 free primary care clinics across 9 states
The initiative, funded entirely under the company’s CSR programme, is expected to reach over a million lives
The initiative, funded entirely under the company’s CSR programme, is expected to reach over a million lives
CagriSema produced a 23% weight loss at 84 weeks, versus 25.5% for tirzepatide
The Phase 2 trial, conducted through Starton’s Sargon Site Network, is expanding from two to six sites across the U.S.
Investment marks continued progress against AbbVie's $100 billion commitment to U.S. R&D and capital investments, including manufacturing, over the next decade
The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies
The program offers selected participants advanced access to Promise Bio’s broad-epiproteomic platform
The collaboration merges biomodal’s 5-base and 6-base sequencing solutions, duet +modC and duet evoC
The funding comes under the AHG Catalysing Innovation Awards, part of the Addiction Healthcare Goals programme led by the Office for Life Sciences
The study is a collaboration between AIM, AstraZeneca, and Erasmus Medical Center in the Netherlands
The decision follows compelling data from the AMPLIFY Phase III trial, demonstrating that 77% of patients receiving the Calquence-venetoclax combination were progression-free at three years
Subscribe To Our Newsletter & Stay Updated
